---
schema_version: "secwatch.filing_event.v1"
accession: "0001842952-23-000070"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T21:47:14.663980+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Context Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Non-compliance with Minimum Bid Price Rule first disclosed on Jan 24, 2023; initial cure period ran to July 24, 2023.
- On June 15, 2023, Nasdaq confirmed the company's common stock had a closing bid price of $1.00+ for 10 consecutive business days.
- Nasdaq considers the matter closed; the company has regained compliance with Listing Rule 5550(a)(2).

## SEC filing metadata
- accession: 0001842952-23-000070
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000184295223000070/0001842952-23-000070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000184295223000070/cntx-20230615.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001842952-23-000070
- JSON: https://secwatch.observer/filing/0001842952-23-000070.json
- Plain text: https://secwatch.observer/filing/0001842952-23-000070.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.